Ding and Liu., 2019 discovered that OGFRP1 was a risky lncRNA in LUAD, and that OGFRP1 increased the proliferation, migration, and invasion of non-small cell lung cancer through the miR-4640–5p/eIF5A axis (Liu et al., 2021b). Furthermore, OGFRP1 acts as an oncogene in prostate cancer (Wang et al., 2021), endometrial cancer (Lv et al., 2019) and gastric cancer (Zhang et al., 2021a). This evidence concerns the gene OGFRP1 and endometrial cancer.